- Author:
Anna NORDENSTRÖM
1
;
Svetlana LAJIC
;
Henrik FALHAMMAR
Author Information
- Publication Type:Review Article
- From:Endocrinology and Metabolism 2022;37(4):587-598
- CountryRepublic of Korea
- Language:English
- Abstract: A plethora of negative long-term outcomes have been associated with congenital adrenal hyperplasia (CAH). The causes are multiple and involve supra-physiological gluco- and mineralocorticoid replacement, excess adrenal androgens both intrauterine and postnatal, elevated steroid precursor and adrenocorticotropic hormone levels, living with a congenital condition as well as the proximity of the cytochrome P450 family 21 subfamily A member 2 (CYP21A2) gene to other genes. This review aims to discuss the different long-term outcomes of CAH.